Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean s adenosyl l methionine disulfide tosilate?
Displaying drugs 5876 - 5900 of 6597 in total

2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide

Experimental

2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide

Experimental

(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene

(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene is a solid. This compound belongs to the naphthalenes. These are compounds containing a naphthalene moiety, which consists of two fused benzene rings. Known drug targets of (1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene include naphthalene 1,2-dioxygenase subunit beta and naphthalene 1,2-dioxygenase subunit alpha.
Experimental

Bamethan

Experimental

KUS-121 free acid

Investigational

Ociperlimab

Ociperlimab is under investigation in clinical trial NCT04866017 (A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (Ccrt) in Patients With Stage III Unresectable Non-small Cell Lung Cancer).
Investigational

Benzoylecgonine

Benzoylecgonine is the major metabolite of cocaine. It is formed by hydrolysis of cocaine in the liver, catalysed by carboxylesterases. It is excreted in the urine of cocaine users after processing in the liver. It is the main pharmaceutical ingredient in the investigational drug Esterom, a topical solution used for...
Experimental
Illicit

(-)-menthol 1-propylene glycol carbonate

Experimental

PCO-371

PCO-371 is under investigation in clinical trial NCT02475616 (A Single Ascending Dose Study of PCO371 in Healthy Volunteers).
Investigational

Emodin

Emodin has been investigated for the treatment of Polycystic Kidney.
Investigational

Dezapelisib

Dezapelisib is under investigation in clinical trial NCT02456675 (INCB040093 and INCB040093 Combined With Itacitinib (INCB039110) in Relapsed/refractory Hodgkin Lymphoma).
Investigational

HMI-103

HMI-102 is an investigational gene therapy designed to encode the phenylalanine-4-hydroxylase (PAH) gene, mutated in people with phenylketonuria.
Investigational

Zandatrigine

Zandatrigine is under investigation in clinical trial NCT05226780 (Extension Study to Evaluate How Safe and Tolerable NBI-921352 Is as an Adjunctive Therapy for Participants With SCN8A-DEE).
Investigational

1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate

Experimental

Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate

Experimental

5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide

Experimental

N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide

Experimental

N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide

Experimental

Copper(II) dithiosemicarbazone

Experimental
Investigational

PF-4136309

Investigational

Mezigdomide

Mezigdomide is under investigation in clinical trial NCT05372354 (A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma).
Investigational

Monepantel

Investigational

3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate

Experimental

Diamino-N-[(4S)-5-anilino-4-{[(2S)-2-{[(1R)-1-carboxyethyl]amino}-4-phenylbutanoyl]amino}-5-oxopentyl]methaniminium

Experimental

4-Amino-1-[(1s,3r,4r,7s)-7-Hydroxy-1-(Hydroxymethyl)-2,5-Dioxabicyclo[2.2.1]Hept-3-Yl]-5-Methylpyrimidin-2(1h)-One

Experimental
Displaying drugs 5876 - 5900 of 6597 in total